TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
32.53
-0.97 (-2.90%)
Dec 27, 2024, 4:00 PM EST - Market closed
TG Therapeutics Employees
TG Therapeutics had 264 employees as of December 31, 2023. The number of employees increased by 38 or 16.81% compared to the previous year.
Employees
264
Change (1Y)
38
Growth (1Y)
16.81%
Revenue / Employee
$1,002,992
Profits / Employee
-$54,409
Market Cap
4.67B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Integer Holdings | 10,500 |
RadNet | 8,441 |
Alkermes | 2,100 |
PROCEPT BioRobotics | 626 |
BridgeBio Pharma | 556 |
Crinetics Pharmaceuticals | 290 |
Krystal Biotech | 229 |
Arcellx | 130 |
TGTX News
- 25 days ago - 20 stocks likely to lag the S&P 500 over the next year — for this one reason - Market Watch
- 4 weeks ago - TG Therapeutics to Participate in the Evercore HealthCONx Conference - GlobeNewsWire
- 5 weeks ago - TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewsWire
- 7 weeks ago - TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates - Seeking Alpha
- 7 weeks ago - TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell - Seeking Alpha
- 7 weeks ago - TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - GlobeNewsWire
- 2 months ago - TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update - GlobeNewsWire